Paper33477635
Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma.
Muzaffar J and 3 others. Cancers (Basel), 2021. Cited by 115 papers, by iCite.
Cite this record
ConductScience Library. Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma. Papers, record 33477635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33477635
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References101
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27247226 | Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. | Lancet Oncol | 2016 | https://conductscience.org/library/papers/27247226 | PubMed |
| 2 | 25395239 | Incidence trends of human papillomavirus-related head and neck cancer in Taiwan, 1995-2009. | Int J Cancer | 2015 | https://conductscience.org/library/papers/25395239 | PubMed |
| 3 | 28855542 | Microbial Communities Associated with Primary and Metastatic Head and Neck Squamous Cell Carcinoma - A High Fusobacterial and Low Streptococcal Signature. | Sci Rep | 2017 | https://conductscience.org/library/papers/28855542 | PubMed |
| 4 | 29147608 | The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis. | Oncoimmunology | 2017 | https://conductscience.org/library/papers/29147608 | PubMed |
| 5 | 27718784 | Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27718784 | PubMed |
| 6 | 23817919 | Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. | Am J Epidemiol | 2013 | https://conductscience.org/library/papers/23817919 | PubMed |
| 7 | 28029303 | E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group. | J Clin Oncol | 2017 | https://conductscience.org/library/papers/28029303 | PubMed |
| 8 | 23414589 | Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. | Lancet Oncol | 2013 | https://conductscience.org/library/papers/23414589 | PubMed |
| 9 | 20697079 | Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20697079 | PubMed |
| 10 | 31308358 | Clinical update on head and neck cancer: molecular biology and ongoing challenges. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31308358 | PubMed |
| 11 | 26402479 | Oncologic Outcomes After Transoral Robotic Surgery: A Multi-institutional Study. | JAMA Otolaryngol Head Neck Surg | 2015 | https://conductscience.org/library/papers/26402479 | PubMed |
| 12 | 25631445 | Comprehensive genomic characterization of head and neck squamous cell carcinomas. | Nature | 2015 | https://conductscience.org/library/papers/25631445 | PubMed |
| 13 | 29467336 | Frameshift events predict anti-PD-1/L1 response in head and neck cancer. | JCI Insight | 2018 | https://conductscience.org/library/papers/29467336 | PubMed |
| 14 | 26359337 | Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. | Science | 2015 | https://conductscience.org/library/papers/26359337 | PubMed |
| 15 | 16161069 | Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). | Head Neck | 2005 | https://conductscience.org/library/papers/16161069 | PubMed |
| 16 | 21224273 | Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. | Int J Epidemiol | 2011 | https://conductscience.org/library/papers/21224273 | PubMed |
| 17 | 25765070 | Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. | Science | 2015 | https://conductscience.org/library/papers/25765070 | PubMed |
| 18 | 19276448 | E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. | J Natl Cancer Inst | 2009 | https://conductscience.org/library/papers/19276448 | PubMed |
| 19 | 24583792 | Phase I dendritic cell p53 peptide vaccine for head and neck cancer. | Clin Cancer Res | 2014 | https://conductscience.org/library/papers/24583792 | PubMed |
| 20 | 20878955 | Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites. | Int J Cancer | 2011 | https://conductscience.org/library/papers/20878955 | PubMed |
Cited by90
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42924143 | Heat shock factor 1 promotes cell migration and predicts poor prognosis in oral squamous cell carcinoma. | J Dent Sci | 2026 | https://conductscience.org/library/papers/42924143 | PubMed |
| 42374269 | Nano-silymarin combined with methylene blue photodynamic therapy versus monotherapies of head and neck squamous cell carcinoma: in-vitro study. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42374269 | PubMed |
| 42327668 | Efficacy and safety of PD-1 inhibitors in recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis. | Oncol Rev | 2026 | https://conductscience.org/library/papers/42327668 | PubMed |
| 42166302 | Clinical and economic burden of recurrence among older patients with locoregionally advanced head and neck squamous cell carcinoma in the United States. | J Manag Care Spec Pharm | 2026 | https://conductscience.org/library/papers/42166302 | PubMed |
| 42115274 | Integrated bioinformatics approaches and expression assays identified a potential prognostic biomarker in oral squamous cell carcinoma. | Sci Rep | 2026 | https://conductscience.org/library/papers/42115274 | PubMed |
| 41940897 | Unraveling the molecular landscape: an overview on gene expression, epigenetic alterations, and therapeutic challenges in head and neck squamous cell carcinoma. | Mol Genet Genomics | 2026 | https://conductscience.org/library/papers/41940897 | PubMed |
| 41890969 | Insufficient erythrocyte-derived S1P: A pathogenic driver and diagnostic biolipid for tumor progression. | iScience | 2026 | https://conductscience.org/library/papers/41890969 | PubMed |
| 41683568 | TRPM2 Channel Involvement in the Hesperidin-Mediated Potentiation of Cisplatin's Antitumor Action in Laryngeal Carcinoma Cells. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683568 | PubMed |
| 41668805 | Circular RNA hsa-circ-0001030 suppresses proliferation and cisplatin tolerance in TSCC via interaction with PKM2. | Cancer Drug Resist | 2026 | https://conductscience.org/library/papers/41668805 | PubMed |
| 41612054 | Impact of the surgery to radiotherapy interval on oncological outcomes in squamous cell carcinoma of the oral tongue. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41612054 | PubMed |
| 41259290 | Inverse Correlation between Endoplasmic Reticulum Stress Intensity and Antitumor Immune Response with Ruthenium(II)-Based Photosensitizers for the Photodynamic Therapy of Head and Neck Squamous Cell Carcinoma. | J Med Chem | 2025 | https://conductscience.org/library/papers/41259290 | PubMed |
| 41222766 | Identification of 5mC regulatory factors mediating methylation patterns and prognosis models in head and neck squamous cell carcinoma. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41222766 | PubMed |
| 41178481 | A systematic review and network meta-analysis of therapies for locally advanced head and neck squamous cell carcinoma with different HPV status. | Acta Otorhinolaryngol Ital | 2025 | https://conductscience.org/library/papers/41178481 | PubMed |
| 41083026 | Clinically Interpretable Survival Risk Stratification in Head and Neck Cancer Using Bayesian Networks and Markov Blankets. | Int J Radiat Oncol Biol Phys | 2026 | https://conductscience.org/library/papers/41083026 | PubMed |
| 40985049 | CRISPR Screens Identify PIK3C2A as a Novel Mediator of EGFR Inhibitor Resistance in Head and Neck Squamous Cell Carcinoma. | Head Neck | 2026 | https://conductscience.org/library/papers/40985049 | PubMed |
| 40877432 | The antitumor effect of tlr4 inhibition in head and neck cancer cell lines. | Sci Rep | 2025 | https://conductscience.org/library/papers/40877432 | PubMed |
| 40752846 | The influence of soluble epoxide hydrolase inhibition and their PUFA-derived epoxides in osteoblast bone metabolism: an in vitro study. | Biochim Biophys Acta Mol Cell Biol Lipids | 2025 | https://conductscience.org/library/papers/40752846 | PubMed |
| 40597034 | VEGFA (rs1570360, rs699947, rs3025033, rs2146323, rs3024997) genotypes in patients with laryngeal squamous cell carcinoma. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40597034 | PubMed |
| 40538851 | Real-world treatment patterns and survival outcomes in patients with locally advanced squamous cell carcinoma of the head and neck in Germany using claims data. | Front Oncol | 2025 | https://conductscience.org/library/papers/40538851 | PubMed |
| 40474706 | Immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma: PD-L1 and beyond. | Pathologica | 2025 | https://conductscience.org/library/papers/40474706 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33477635
GET https://conductscience.org/api/papers/v1/33477635/references?page=2